Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.
about
Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.Efficacy and Toxicity of Low-Dose versus Conventional-Dose Chemotherapy for Malignant Tumors: a Meta-Analysis of 6 Randomized Controlled TrialsXELOX in colorectal cancer: a convenient option for the future?Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines.
P2860
Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.
@en
Two Doses of oxaliplatin with capecitabine
@nl
type
label
Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.
@en
Two Doses of oxaliplatin with capecitabine
@nl
prefLabel
Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.
@en
Two Doses of oxaliplatin with capecitabine
@nl
P2093
P356
P1476
Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer
@en
P2093
Edmon Pou-Sanchis
Francisco Martínez-Ródenas
Isabel Moreno-Solórzano
José Moreno-Solórzano
Mariano Monzó-Planella
Marta Navarro-Vigo
Rafael Ibeas-Rollan
Raquel Hernández-Borlan
Silvia Ortigosa-Rodríguez
P304
P356
10.3816/CCC.2007.N.031
P407
P50
P577
2007-09-01T00:00:00Z